Featured Research

from universities, journals, and other organizations

DMP1 protein inhibits angiogenesis, could lead to new treatments against cancer and other diseases

Date:
January 27, 2011
Source:
University of Liège
Summary:
Researchers in Belgium have demonstrated that the DMP1 protein has previously unsuspected anti-angiogenic activities which could be used for the development of new treatments against cancer, but also against diseases in which angiogenesis (the formation of new blood vessels) plays a major role, such as psoriasis, rheumatoid arthritis or diabetic retinopathy.

A team from the Metastasis Research Laboratory (GIGA-Cancer/Liège University Hospital) has just published, in the journal Blood, their work demonstrating that the DMP1 protein has previously unsuspected anti-angiogenic activities which could be used for the development of new treatments against cancer, but also against diseases in which angiogenesis (the formation of new blood vessels) plays a major role, such as psoriasis, rheumatoid arthritis or diabetic retinopathy.

This discovery has also led to the registering of a patent by the three research protagonists: Doctor Akeila Bellahcène, a Senior Research Associate at the National Fund for Scientific Research (NFSR) who is running the project, Sophie Pirotte, a TELEVIE (NFSR) researcher, and Professor Vincent Castronovo, the Laboratory's Director.

Dr Bellahcène has been interested in SIBLINGs proteins for several years. They are a family of glycoproteins initially discovered for their role in the formation of bones and teeth. It is now over fifteen years ago that the Liège laboratory was the first to show that two of these proteins, bone sialoprotein (BSP) and osteopontin (OPN), are produced by cancer cells and probably play a role in the progression of these cancers, notably through their involvement in the formation of bone metastases. These original observations, confirmed by other international teams, opened the way for numerous projects studying the role played by these two proteins in cancer. Up until recently, DMP1, known above all for its role in teeth mineralisation, had not attracted attention in terms of a role in the development and progression of cancer.

But Doctor Akeila Bellahcène's most recent research demonstrates that DMP1 also deserves very special attention. In effect the results published in the journal Blood show that DMP1 is capable of blocking angiogenesis. Yet angiogenesis is vital for the development of tumours beyond a few cubic millimetres, as well as for the formation of metastases.

The work shows that DMP1 prevents endothelial cells (the cells which form new blood vessels over the course of angiogenesis) to respond to VEGF, a molecular signal sent by cancer cells to activate the formation of new feeder blood vessels. The presence of DMP1 halts the different stages which lead to the formation of new capillaries: the endothelial cells are placed in a resting non proliferative state.

"In an in vivo model of angiogenesis linked to tumour development, we have shown that the tumours from cancer cells in which we had beforehand overexpressed DMP1 had a reduced growth combined with very modest vascularisation in comparison with the control tumours," points out Doctor Bellahcène.

"These results overall indicate that DMP1 could represent a new anti-angiogenesis molecule whose therapeutic implications would moreover go beyond their use in cancer pathology," states Professor Vincent Castronovo, who directs the Metastasis Research Laboratory at the ULg's GIGA-ResearchUnit. "In effect the processes of angiogenesis induced by VEGF also intervene in a significant manner in the development and progression of other pathologies such as rheumatoid arthritis, psoriasis and diabetic retinopathy."


Story Source:

The above story is based on materials provided by University of Liège. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Pirotte, V. Lamour, V. Lambert, M.-L. Alvarez Gonzalez, S. Ormenese, A. Noel, D. Mottet, V. Castronovo, A. Bellahcene. Dentin Matrix Protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood, 2010; DOI: 10.1182/blood-2010-08-298810

Cite This Page:

University of Liège. "DMP1 protein inhibits angiogenesis, could lead to new treatments against cancer and other diseases." ScienceDaily. ScienceDaily, 27 January 2011. <www.sciencedaily.com/releases/2011/01/110126101606.htm>.
University of Liège. (2011, January 27). DMP1 protein inhibits angiogenesis, could lead to new treatments against cancer and other diseases. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2011/01/110126101606.htm
University of Liège. "DMP1 protein inhibits angiogenesis, could lead to new treatments against cancer and other diseases." ScienceDaily. www.sciencedaily.com/releases/2011/01/110126101606.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins